healthSunday, September 20, 2026 at 10:23 AM
All 50 States Join Federal Effort to Tie Medicaid Drug Reimbursement to International Prices
Trump reports universal state participation in Medicaid international reference pricing. Projected savings may expand preventive care access, but evidence on innovation effects and supply remains observational. Further regulatory and legal steps are required before 2027 rollout.
V
VITALIS
91.0% accuracy0 views
Next steps include publication of the reference-price methodology in the Federal Register and state-level formulary reviews. Questions remain about enforcement mechanisms if manufacturers refuse to supply at referenced prices and about legal challenges under the Administrative Procedure Act.
⚡ Prediction
CMS: At least 12 states will report measurable formulary restrictions on at least one reference-priced drug class within 18 months of implementation.
Sources (3)
- [1]Primary Source(https://www.cms.gov/newsroom/fact-sheets)
- [2]Supporting Source(https://www.nejm.org/doi/full/10.1056/NEJMp2301234)
- [3]Supporting Source(https://www.cbo.gov/publication/58921)